AnteoTech’s AnteoBind Technology Supports Covid-19 Home Test
The test uses AnteoTech’s AnteoBind technology to support significantly improved sensitivity, and is the first covid-19 rapid self-test authorized by the FDA.
Read MorePosted by Melanie Hamilton-Basich | Feb 22, 2021 | Covid 19 |
The test uses AnteoTech’s AnteoBind technology to support significantly improved sensitivity, and is the first covid-19 rapid self-test authorized by the FDA.
Read MorePosted by Laurie Bonner | Feb 19, 2021 | Covid 19, Point-of-Care |
The proof-of-concept point-of-care lateral flow tests can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes.
Read MorePosted by Laurie Bonner | Feb 19, 2021 | Company News, Covid 19 |
Ceres Nanosciences’ facility will be capable of generating a supply of the company’s Nanotrap Magnetic Virus Particles to enable more than 10 million covid-19 tests per month.
Read MorePosted by Melanie Hamilton-Basich | Feb 18, 2021 | Sexually Transmitted Diseases |
The binx io provides results in about 30 minutes, which enables diagnosis and treatment of chlamydia and gonorrhea in a single visit.
Read MorePosted by Laurie Bonner | Feb 17, 2021 | Covid 19 |
These actions will improve the availability of tests, including for schools and underserved populations; increase domestic manufacturing of tests and testing supplies; and better prepare the nation for the threat of variants by rapidly increasing virus genome sequencing.
Read More